External Science Review Board To "Audit" CDRH, Interview E-Stim Reps
This article was originally published in The Gray Sheet
An external committee assigned to perform a review of scientific decisions and processes at the Center for Devices and Radiological Health will have the opportunity to interview industry members in the electronic stimulation device area, according to CDRH Director David Feigal.
You may also be interested in...
CDRH's fiscal year 2001 "science review" will focus on the agency's regulation of electrical stimulation devices as a case study.
Amarin had argued that Vascepa’s sales success showed that its patents were not obvious, but the court found otherwise, even as it concluded that Hikma, Dr. Reddy's and West-Ward has infringed on the fish oil pill's patents.
Grail announced results from an initial validation study that showed its early-detection blood test could identify 12 of the deadliest cancers with a low rate of false-positive results.